Jennifer Culhane
Associate Research ScientistDownloadHi-Res Photo
Cards
Contact Info
About
Titles
Associate Research Scientist
Appointments
Obstetrics, Gynecology & Reproductive Sciences
Associate Research ScientistPrimary
Other Departments & Organizations
Research
Research at a Glance
Yale Co-Authors
Frequent collaborators of Jennifer Culhane's published research.
Publications Timeline
A big-picture view of Jennifer Culhane's research output by year.
Lisbet Lundsberg, PhD
Caitlin Partridge
Moeun Son, MD, MSCI, FACOG
Annalies Denoble, MD, MSc
Audrey Merriam, MD, MS
Uma Reddy, MD, MPH
115Publications
2,641Citations
Publications
2024
Association Between Intrapartum Nitrous Oxide for Labor Analgesia and Short-Term Neonatal Outcomes
Starosta A, Lundsberg L, Culhane J, Partridge C, Grechukhina O, Son M. Association Between Intrapartum Nitrous Oxide for Labor Analgesia and Short-Term Neonatal Outcomes. Obstetric Anesthesia Digest 2024, 44: 227-228. DOI: 10.1097/01.aoa.0001080268.73398.1f.Peer-Reviewed Original ResearchConceptsShort-term neonatal outcomesNeonatal outcomesAdverse short-term neonatal outcomesAssociated with adverse neonatal outcomesAdverse neonatal outcomesInhaled nitrous oxideLabor analgesiaNeuraxial analgesiaSystemic opioidsNo significant differenceSignificant differenceIntrapartumShort-term effectsAnalgesiaOutcomesInhaled gasUnited StatesAssociationNeonatesOpioidPlacentaPainNitrous oxideThe early COVID-19 pandemic period and associated gestational weight gain
Madein A, Lundsberg L, Culhane J, Partridge C, Son M, Merriam A. The early COVID-19 pandemic period and associated gestational weight gain. Journal Of Perinatal Medicine 2024, 0 PMID: 39485230, DOI: 10.1515/jpm-2024-0088.Peer-Reviewed Original ResearchConceptsGestational weight gainGestational ageWeight gainAssociated with weight gainInstitute of MedicineMaternal weight gainWeight gain riskRetrospective cohort studyInstitute of Medicine recommendationsTertiary care hospitalNo significant differenceEarly pandemic periodCohort studyPrimary outcomeMedical record dataCare hospitalPandemic groupPandemic epochSignificant differenceLogistic regressionElectronic medical record dataExposure groupMultinominal logistic regressionPandemic periodAgeLate-Onset Postpartum Hypertension After Normotensive Pregnancy.
Sinnott C, Lundsberg L, Culhane J, Partridge C, Denoble A. Late-Onset Postpartum Hypertension After Normotensive Pregnancy. Obstetrics And Gynecology 2024 PMID: 39361961, DOI: 10.1097/aog.0000000000005751.Peer-Reviewed Original ResearchAltmetricConceptsMonths postpartumAcademic health care systemHealth care systemElectronic medical recordsPostpartum carePrimary careRetrospective cohort studyBlood pressureCare systemEvidence of hypertensionWeeks postpartumPostpartum periodCohort studyPostpartum hypertensionPostpartumAmerican CollegeImmediately postpartumMedical recordsAssociation criteriaCareNormotensive pregnanciesBP abnormalitiesNormotensive cohortLate-onsetPregnancySevere maternal morbidity in polycystic ovary syndrome
McKenney K, Culhane J, Son M, Burris H, Handley S, Greenspan J, Dysart K. Severe maternal morbidity in polycystic ovary syndrome. American Journal Of Obstetrics & Gynecology MFM 2024, 6: 101448. PMID: 39095022, DOI: 10.1016/j.ajogmf.2024.101448.Peer-Reviewed Original ResearchCitationsFor Patients Undergoing an Induction of Labor, Does Increased Body Mass Index Necessitate Higher Doses of Misoprostol? [ID 2683640]
Mason-Otey A, Lundsberg L, Culhane J, Merriam A. For Patients Undergoing an Induction of Labor, Does Increased Body Mass Index Necessitate Higher Doses of Misoprostol? [ID 2683640]. Obstetrics And Gynecology 2024, 143: 46s-46s. DOI: 10.1097/01.aog.0001013576.14925.24.Peer-Reviewed Original ResearchConceptsInduction of laborBody mass indexBody mass index categoriesDose of misoprostolMisoprostol doseClass IIIMass indexProlonged induction of laborClass IIAssociated with increased BMIClass IIncreased BMIPre-gestational diabetesClass II obesityClass I obesityRetrospective cohort analysisMisoprostol administrationObese patientsII obesityMisoprostolInvestigate safetyHigh dosesPrimary outcomeCohort analysisPatientsAssociation Between Intrapartum Nitrous Oxide for Labor Analgesia and Short-Term Neonatal Outcomes
Starosta A, Lundsberg L, Culhane J, Partridge C, Grechukhina O, Son M. Association Between Intrapartum Nitrous Oxide for Labor Analgesia and Short-Term Neonatal Outcomes. Obstetrics And Gynecology 2024, 143: 677-682. PMID: 38484306, DOI: 10.1097/aog.0000000000005554.Peer-Reviewed Original ResearchCitationsAltmetricConceptsShort-term neonatal outcomesNeonatal intensive care unitNo analgesiaNeonatal outcomesApgar scoreLabor analgesiaComposite outcomeAdverse short-term neonatal outcomesNeonatal intensive care unit admissionSecondary outcomesSingle-center retrospective cohortRetrospective cohort study of individualsCohort study of individualsLow-risk patientsRetrospective cohort studyIntensive care unitElectronic medical recordsNitrous oxide useAnalgesia typeIntrapartum cesareanSingleton gestationsNICU admissionNitrous oxide exposureIntrapartum analgesiaNeonatal hyperbilirubinemiaAbsence of Adverse Maternal and Neonatal Outcomes in Patients with 1 or 2 Abnormal Values During Early Glucose Tolerance Testing
Geng B, Lundsberg L, Culhane J, Merriam A. Absence of Adverse Maternal and Neonatal Outcomes in Patients with 1 or 2 Abnormal Values During Early Glucose Tolerance Testing. American Journal Of Obstetrics And Gynecology 2024, 230: e103-e107. PMID: 38242338, DOI: 10.1016/j.ajog.2024.01.007.Peer-Reviewed Original ResearchAltmetricRate of clinically significant red blood cell antibody seroconversion in pregnancy
Ding J, Abels E, Jacobs J, Culhane J, Lundsberg L, Partridge C, Denoble A, Kohari K. Rate of clinically significant red blood cell antibody seroconversion in pregnancy. The Journal Of Maternal-Fetal & Neonatal Medicine 2024, 37: 2419370. PMID: 39462637, DOI: 10.1080/14767058.2024.2419370.Peer-Reviewed Original ResearchMeSH Keywords and ConceptsConceptsNeonatal intensive care unitAdvanced maternal ageAssociated with seroconversionClinically significant antibodiesAntibody screeningNeonatal outcomesIncreasing gravidityAntibody seroconversionInitial hemoglobinMaternal ageSignificant antibodiesAntibody statusNeonatal intensive care unit admissionCohort studyClinically significant RBC antibodiesAnti-CUnexplained fetal lossPositive antibody screenNegative antibody screenCases of stillbirthRetrospective cohort studyIntensive care unitWilcoxon rank-sumMaternal antibody statusPostnatal transfusionCo-existing chronic hypertension and hypertensive disorders of pregnancy and associated adverse pregnancy outcomes
Sweeney L, Lundsberg L, Culhane J, Partridge C, Son M. Co-existing chronic hypertension and hypertensive disorders of pregnancy and associated adverse pregnancy outcomes. The Journal Of Maternal-Fetal & Neonatal Medicine 2024, 37: 2305675. PMID: 38290827, DOI: 10.1080/14767058.2024.2305675.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsHypertensive disorders of pregnancyDisorders of pregnancyNeonatal outcomesChronic hypertensionHypertensive disordersIntensive care unitCesarean deliveryOdds of cesarean deliveryPregnant personsBlood pressureBivariate tests of associationHypertensive conditionsMaternal ICU admissionPreterm birth <Intensive care unit admissionAntihypertensive medication useBaseline clinical dataElectronic medical recordsTests of associationRetrospective cohort studySGA birthweightEligible peopleGestational ageMaternal comorbiditiesSingleton deliveries284 Postpartum diabetes screening rates and 1-year outcomes for individuals with early onset gestational diabetes
Pifer B, Geng B, Lundsberg L, Culhane J, Partridge C, Merriam A. 284 Postpartum diabetes screening rates and 1-year outcomes for individuals with early onset gestational diabetes. American Journal Of Obstetrics And Gynecology 2024, 230: s163-s164. DOI: 10.1016/j.ajog.2023.11.306.Peer-Reviewed Original Research
Get In Touch
Contacts
Academic Office Number
Secondary Academic Office Number
Clinic Fax Number